Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene Symbol | CBL | ||||||||||||
| Synonyms | C-CBL | CBL2 | FRA11B | NSLL | RNF55 | ||||||||||||
| Gene Description | CBL, Cbl proto-oncogene, is an E3 ubiquitin-protein ligase involved in cell signaling and ubiquitination of tyrosine kinases (PMID: 23085373). CBL mutations, often resulting in a loss of function, have been identified primarily in myeloid neoplasms, including myelodysplastic syndrome, acute myeloid leukemia, chronic myeloid leukemia, myelofibrosis, and juvenile myelomonocytic leukemia (PMID: 25477533). | ||||||||||||
|
|||||||||||||
| Variant | Impact | Protein Effect | Variant Description | Associated With Drug Resistance |
|---|
| Variant | Impact | Protein Effect | Variant Description | Associated With Drug Resistance |
|---|
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|